Good question. I know we have been focused on Afrezza, but I'm curious about other projects in the pipeline.

This is in addition to the tecnology that is Dreamboat. I understand that the value of this Company goes beyond Afrezza and their own internal projects. The licensing of their drug delivery system for other applications could have potential impacts greater than the approval of Afrezza.

Unfortunately, I do not have the capability to quantify such potential. If someone can quantify, I'm all ears.